STUDY ON BACTERIAL DISTRIBUTION CHARACTERISTICS AND ANTIBIOTIC RESISTANCE IN PATIENTS WITH COMMUNITY INFECTIONS

Thanh Xuân Nguyễn, Văn Thuần Nguyễn, Văn Luyến Nguyễn, Thị Hạnh Nguyễn, Thùy Dung Nguyễn, Thị Thu Vân Hà, Huyền Trang Nguyễn

Main Article Content

Abstract

Objective: Survey of bacterial characteristics and antibiotic resistance in patients with community-acquired pneumonia (CAP) and community-acquired urinary tract infection (CA-UTI) at Military Hospital 103. Subjects and methods: Cross-sectional descriptive study including 35 patients diagnosed with CAP or CA-UTI admitted to Hospital 103 from December 2024 to April 2025. Clinical data and bacterial culture results were collected. Bacteria were identified and tested for antibiotic resistance using the VITEK 2 system. Results: Mean age 69.4 ± 17.6 years; female: 57.1%. CA-UTI: 68.6%, CAP: 31.4%. Escherichia coli predominated in CA-UTI (66.7%, 16/24); in CAP E. coli and Klebsiella pneumoniae each accounted for 27.3%. All strains were multidrug-resistant (MDR). The number of underlying diseases was associated with the level of resistance (β=0.83, p=0.010). Carbapenems were most effective (>77%), Gentamicin ~57%, Cephalosporin ~48–49%. Ciprofloxacin and TMP-SMX were least effective. Conclusion: Gram-negative bacteria predominated in both CAP (81.8%) and CA-UTI (95.8%). Both groups of bacteria had high levels of resistance. More underlying diseases were associated with higher levels of resistance. Carbapenems remained effective against multidrug-resistant strains; some oral antibiotics (fosfomycin, nitrofurantoin) can be considered for uncomplicated UTI.

Article Details

References

1. Thi Kieu Anh Tran, Van Tuan Nguyen. Nghiên cứu thực trạng sử dụng kháng sinh trong điều trị bệnh viêm phổi ở trẻ 2 tháng đến 5 tuổi tại Bệnh viện Sản Nhi Nghệ An năm 2021. Vietnam Medical Journal. Tập 505 Số 1 (2021). 254-257.
2. [Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3): 268-281. doi:10.1111/j.1469-0691. 2011.03570.x
3. Airhihenbuwa CO, Tseng TS, Sutton VD, Price L. Global Perspectives on Improving Chronic Disease Prevention and Management in Diverse Settings. Prev Chronic Dis. 2021 Apr 8;18:E33. doi: 10.5888/pcd18.210055. PMID: 33830913; PMCID: PMC8051856.
4. Montoya A, Mody L. Common infections in nursing homes: a review of current issues and challenges. Aging health. 2011;7(6):889-899. doi:10.2217/AHE.11.80.
5. Eshwarappa M, Dosegowda R, Aprameya IV, Khan MW, Kumar PS, Kempegowda P. Clinico-microbiological profile of urinary tract infection in south India. Indian J Nephrol. 2011;21(1):30-36. doi:10.4103/0971-4065.75226.
6. Osman M, Manosuthi W, Kaewkungwal J, et al. Etiology, Clinical Course, and Outcomes of Pneumonia in the Elderly: A Retrospective and Prospective Cohort Study in Thailand. Am J Trop Med Hyg. 2021;104(6):2009-2016. Published 2021 May 3. doi:10.4269/ajtmh.20-1393.
7. Farhan SM, Raafat M, Abourehab MAS, et al. Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa. Antibiotics (Basel). 2021;10(11): 1429. Published 2021 Nov 22. doi:10.3390/ antibiotics10111429.
8. Sheu CC, Chang YT, Lin SY, Chen YH, Hsueh PR. Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options. Front Microbiol. 2019;10:80. Published 2019 Jan 30. doi:10.3389/fmicb. 2019.00080.